Dyne Therapeutics Inc (NASDAQ: DYN) is -69.35% lower on its value in year-to-date trading and has touched a low of $6.36 and a high of $47.45 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The DYN stock was last observed hovering at around $10.32 in the last trading session, with the day’s loss setting it -7.59%.
Currently trading at $2.73M, the stock is -20.62% and -11.45% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.81 million and changing 1810691% at the moment leaves the stock -49.61% off its SMA200. DYN registered -56.88% loss for a year compared to 6-month loss of -61.16%.
The stock witnessed a -13.61% gain in the last 1 month and extending the period to 3 months gives it a -15.89%, and is -29.49% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 11.05% over the week and 6.26% over the month.
Dyne Therapeutics Inc (DYN) has around 191 employees, a market worth around $1.15B and $0.00M in sales. Distance from 52-week low is 59.75% and -78.59% from its 52-week high. The company has generated returns on investments over the last 12 months (-53.42%).
The EPS is expected to shrink by -15.71% this year.
Dyne Therapeutics Inc (DYN) Top Institutional Holders
The shares outstanding are 113.63M, and float is at 85.23M with Short Float at 29.95%.
The top institutional shareholder in the company is ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC with over 8.02 million shares valued at $283.03 million. The investor’s holdings represent 8.6697% of the DYN Shares outstanding. As of 2024-06-30, the second largest holder is FCPM III SERVICES B.V. with 7.85 million shares valued at $276.86 million to account for 8.4808 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 7.39 million shares representing 7.9853% and valued at over $260.69 million, while RTW INVESTMENTS, LP holds 6.9044 of the shares totaling 6.39 million with a market value of $225.4 million.
Dyne Therapeutics Inc (DYN) Insider Activity
Still, SEC filings show that on Jun 05 ’25, Cox John (CEO & President) disposed off 4,060 shares at an average price of $13.35 for $54201.0. The insider now directly holds 142,179 shares of Dyne Therapeutics Inc (DYN).
